Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:17:45 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



Q:RGEN - REPLIGEN CORP - http://www.repligen.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RGEN - Q1.0163.30·174.000.1166.58+0.920.6341.356,5276,804165.66  168.455  165.045211.13  110.4516:03:06Apr 1715 min RT 2¢

Recent Trades - Last 10 of 6804
Time ETExPriceChangeVolume
16:03:06Q163.30-2.361
16:02:19Q166.580.9228
16:02:17Q166.580.9235
16:02:14Q166.580.92984
16:01:48Q166.580.9245
16:01:46Q166.580.929
16:01:28Q166.580.92131
16:01:23Q166.580.924
16:01:21Q166.580.9230
16:01:04Q166.580.922

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-17 07:30U:RGENNews ReleaseRepligen to Report First Quarter 2024 Financial Results
2024-03-19 07:30U:RGENNews ReleaseRepligen Appoints Maggie A. Pax to Board of Directors
2024-02-21 07:30U:RGENNews ReleaseRepligen Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-07 07:30U:RGENNews ReleaseRepligen to Report Fourth Quarter and Full Year 2023 Financial Results
2023-12-19 07:30U:RGENNews ReleaseRepligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
2023-12-07 07:30U:RGENNews ReleaseRepligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements
2023-11-14 14:02U:RGENNews ReleaseUPDATE ¢ € “ Repligen Announces Publication of the Company ¢ € ™s 2022 Sustainability Report
2023-11-14 07:30U:RGENNews ReleaseRepligen Announces Publication of the Company ¢ € ™s 2022 Sustainability Report
2023-11-07 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming Investor Conferences
2023-11-02 07:30U:RGENNews ReleaseRepligen Launches TangenX ‚ ® SC as First-to-Market Holder-Free Self-Contained TFF Device
2023-10-31 07:30U:RGENNews ReleaseRepligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
2023-10-17 07:30U:RGENNews ReleaseRepligen to Report Third Quarter 2023 Financial Results
2023-10-02 07:30U:RGENNews ReleaseRepligen Appoints Olivier Loeillot as President and Chief Commercial Officer
2023-09-26 07:30U:RGENNews ReleaseRepligen Announces Agreement to Acquire Fluid Management Innovator Metenova
2023-09-12 07:30U:RGENNews ReleaseRepligen Appoints Jason K. Garland as Chief Financial Officer
2023-09-01 07:30U:RGENNews ReleaseRepligen Corporation to Present at Wells Fargo Healthcare Conference
2023-08-17 08:00U:RGENNews ReleaseSartorius and Repligen Corporation Launch Integrated System with Biostat STR ‚ ® and XCell ‚ ® ATF for Upstream Process Intensification
2023-08-02 07:30U:RGENNews ReleaseRepligen Reports Second Quarter 2023 Financial Results ‚  and Updates Full Year 2023 Financial Guidance
2023-07-19 07:30U:RGENNews ReleaseRepligen to Report Second Quarter 2023 Financial Results
2023-05-31 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming Investor Conferences